Compare Budi Starch Sweetener Tbk (BUDI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Budi Starch Sweetener Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp206 (market cap 926.79B, 36.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Budi Starch Sweetener Tbk is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 36.6K). Which is the better fit depends on your goals.
| BUDI | LABS | |
|---|---|---|
Market Cap | 926.79B | 576.7B |
Volume | 36.6K | 3.48M |
Lot | 366 | 34.82K |
Turnover | 7.54M | 522.79M |
Average Price | 206 | 150.13 |
Value | 7.54M | 522.79M |
Indicative Equilibrium Price | 206 | 148 |
Indicative Equilibrium Volume | 46 | 350 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Budi Starch Sweetener Tbk
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
